KA
GEHC icon

Klingman & Associates’s GE HealthCare GEHC Stock Holding History

Klingman & Associates’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
3,285
-700
-18% -$46K 0.01% 335
2026
Q1 		$284K Buy
3,985
+253
+7% +$20K 0.01% 270
2025
Q4 		$306K Buy
3,732
+98
+3% +$7.64K 0.01% 252
2025
Q3 		$273K Buy
3,634
+139
+4% +$10.4K 0.01% 270
2025
Q2 		$259K Sell
3,495
-1,716
-33% -$119K 0.01% 269
2025
Q1 		$421K Buy
5,211
+23
+0.4% +$1.98K 0.03% 177
2024
Q4 		$406K Sell
5,188
-2,056
-28% -$175K 0.02% 175
2024
Q3 		$680K Buy
7,244
+3,788
+110% +$318K 0.04% 133
2024
Q2 		$269K Buy
3,456
+559
+19% +$45.6K 0.02% 206
2024
Q1 		$263K Buy
2,897
+38
+1% +$3.16K 0.02% 204
2023
Q4 		$221K Buy
+2,859
New +$200K 0.02% 216
2023
Q3 		– Sell
-2,889
Closed -$235K – 224
2023
Q2 		$235K Buy
2,889
+27
+0.9% +$2.15K 0.02% 194
2023
Q1 		$235K Buy
+2,862
New +$204K 0.02% 180

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Klingman & Associates's GEHC Position: Q2 2026 in Review

Klingman & Associates reduced its GE HealthCare (GEHC) stake by 18% in Q2 2026, selling an estimated $46K and leaving 3,285 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #335.

Klingman & Associates first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $680K in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Klingman & Associates held 3,285 shares of GE HealthCare worth $210K as of Q2 2026.
  • Klingman & Associates sold 700 GE HealthCare shares in Q2 2026, an estimated $46K.
  • GE HealthCare made up 0.01% of Klingman & Associates's portfolio in Q2 2026, its #335 holding.
  • Klingman & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Klingman & Associates's GE HealthCare position peaked at $680K in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Klingman & Associates's 13F filing for Q2 2026, filed 29 Jul 2026.